Predictors of infection in post-coronary artery bypass graft surgery;Preditores de infecção no pós-operatório de cirurgia de revascularização miocárdica

Brazilian Journal of Cardiovascular Surgery

Volumn 26, Issue 2, 2011, Pages 190-196

  Ledur, Priscila ^a   Almeida, Lúcia ^b   Pellanda, Lucia Campos ^b   Schaan, Beatriz D'Agord ^b  

^a HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^b INSTITUTO DE CARDIOLOGIA DO RIO GRANDE DO SUL   (Brazil)

Author keywords

Diabetes mellitus; Infection; Myocardial revascularization; Risk

Indexed keywords

ARTICLE; CORONARY ARTERY BYPASS GRAFT; FEMALE; HOSPITALIZATION; HUMAN; INCIDENCE; MALE; MIDDLE AGED; RESPIRATORY TRACT INFECTION; RETROSPECTIVE STUDY; RISK; RISK FACTOR; SURGICAL INFECTION; URINARY TRACT INFECTION;

CORONARY ARTERY BYPASS; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; ODDS RATIO; RESPIRATORY TRACT INFECTIONS; RETROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SURGICAL WOUND INFECTION; URINARY TRACT INFECTIONS;

EID: 80052655745     PISSN: 01027638     EISSN: 16789741     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Booth J, Clayton T, Pepper J, Nugara F, Flather M, Sigwart U, et al. Randomized, controlled trial of coronary artery bypass surgery versus percutaneous coronary intervention in patients with multivessel coronary artery disease: six-year follow-up from the Stent or Surgery Trial (SoS). Circulation. 2008;118(4):381-388.
2. Assunção TP, Pontes BCD, Damasceno CAV. Prevalência de infecções em suturas de cirurgias de revascularização do miocárdio. Rev Bras Cir Cardiovasc. 2011;26(1):43-46.
3. Brito JD, Assumpção CR, Murad H, Jazbik AP, Sá MPL, Bastos ES, et al. Manuseio em um estágio de esternotomia infectada com avanço bilateral de flap miocutâneo do peitoral maior. Rev Bras Cir Cardiovasc. 2009;24(1):58-63.
4. Antoniali F, Costa CE, Tarelho LS, Lopes MM, Albuquerque APN, Reinert GAA, et al. O impacto de mudanças nas medidas de prevenção e no tratamento de infecções incisionais em cirurgia de revascularização do miocárdio. Rev Bras Cir Cardiovasc. 2005;20(4):382-391.
5. Sá MPBO, Soares EF, Santos CA, Figueiredo OJ, Lima ROA, Escobar RR, et al. Fatores de risco para mediastinite após cirurgia de revascularização miocárdica. Rev Bras Cir Cardiovasc. 2011;26(1):27-35.
6. Pinto NC, Pereira MHC, Stolf NAG, Chavantes MC. Laser de baixa intensidade em deiscência aguda de safenectomia: proposta terapêutica. Rev Bras Cir Cardiovasc. 2009;24(1):88-91.
7. Harrington G, Russo P, Spelman D, Borrell S, Watson K, Barr W, et al. Surgical-site infection rates and risk factor analysis in coronary artery bypass graft surgery. Infect Control Hosp Epidemiol. 2004;25(6):472-476.
8. Sá MPBDO, Silva DO, Lima ENS, Lima RC, Silva FPV, Rueda FG, et al. Mediastinite no pós-operatório de cirurgia cardiovascular: análise de 1038 cirurgias consecutivas. Rev Bras Cir Cardiovasc. 2010;25(1):19-24.
9. Guvener M, Pasaoglu I, Demircin M, Oc M. Perioperative hyperglycemia is a strong correlate of postoperative infection in type II diabetic patients after coronary artery bypass grafting. Endocr J. 2002;49(5):531-537.
10. Furnary AP, Gao G, Grunkemeier GL, Wu Y, Zerr KJ, Bookin SO, et al. Continuous insulin infusion reduces mortality in patients with diabetes undergoing coronary artery bypass grafting. J Thorac Cardiovasc Surg. 2003;125(5):1007-1021.
11. Szabó Z, Hakanson E, Svedjeholm R. Early postoperative outcome and medium-term survival in 540 diabetic and 2239 nondiabetic patients undergoing coronary artery bypass grafting. Ann Thorac Surg. 2002;74(3):712-719.
12. Wilson AP, Livesey SA, Treasure T, Grüneberg RN, Sturridge MF. Factors predisposing to wound infection in cardiac surgery. A prospective study of 517 patients. Eur J Cardiothorac Surg. 1987;1(3):158-164.
13. Friedman ND, Bull AL, Russo PL, Leder K, Reid C, Billah B, et al. An alternative scoring system to predict risk for surgical site infection complicating coronary artery bypass graft surgery. Infect Control Hosp Epidemiol. 2007;28(10):1162-1168.
14. Magedanz EH, Bodanese LC, Guaragna JCVC, Albuquerque LC, Martins V, Minossi SD, et al. Elaboração de escore de risco para mediastinite pós-cirurgia de revascularização do miocárdio. Rev Bras Cir Cardiovasc. 2010;25(2):154-159.
15. Bostom AG, Kronenberg F, Ritz E. Predictive performance of renal function equations for patients with chronic kidney disease and normal serum creatinine levels. J Am Soc Nephrol. 2002;13(8):2140-2144.
16. Barros FC, Victora CG. Epidemiologia da Saúde infantil: um manual para diagnósticos comunitários de saúde. 2a ed. São Paulo: Editora Hucitec/Edusp;1994;
17. Blasco-Colmenares E, Perl TM, Guallar E, Baumgartner WA, Conte JV, Alejo D, et al. Aspirin plus clopidogrel and risk of infection after coronary artery bypass surgery. Arch Intern Med. 2009;169(8):788-796.
18. Golden SH, Peart-Vigilance C, Kao WH, Brancati FL. Perioperative glycemic control and the risk of infectious complications in a cohort of adults with diabetes. Diabetes Care. 1999;22(9):1408-1414.
19. The Bypass Angioplasty Revascularization Investigation (BARI) Investigators. Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease. N Engl J Med. 1996;335(4):217-225.
20. Discigil G, Ozkisacik EA, Badak MI, Günes T, Discigil B. Obesity and open-heart surgery in a developing country. Anadolu Kardiyol Derg. 2008;8(1):22-26.
21. Li JY, Sun S, Wu SJ. Continuous insulin infusion improves postoperative glucose control in patients with diabetes mellitus undergoing coronary artery bypass surgery. Tex Heart Inst J. 2006;33(4):445-451.
22. Eklund AM, Lyytikainen O, Klemets P, Huotari K, Anttila VJ, Werkkala KA, et al. Mediastinitis after more than 10,000 cardiac surgical procedures. Ann Thorac Surg. 2006;82(5):1784-1789.
23. Furnary AP, Wu Y, Bookin SO. Effect of hyperglycemia and continuous intravenous insulin infusions on outcomes of cardiac surgical procedures: the Portland Diabetic Project. Endocr Pract. 2004;10(Suppl 2):21-33.
24. Robinson PJ, Billah B, Leder K, Reid CM; ASCTS Database Committee. Factors associated with deep sternal wound infection and haemorrhage following cardiac surgery in Victoria. Interact Cardiovasc Thorac Surg. 2007;6(2):167-171.
25. Fakih MG, Sharma M, Khatib R, Berriel-Cass D, Meisner S, Harrington S, et al. Increase in the rate of sternal surgical site infection after coronary artery bypass graft: a marker of higher severity of illness. Infect Control Hosp Epidemiol. 2007;28(6):655-660.
26. Malerbi DA, Franco LJ. Multicenter study of the prevalence of diabetes mellitus and impaired glucose tolerance in the urban Brazilian population aged 30-69 yr. The Brazilian Cooperative Group on the Study of Diabetes Prevalence. Diabetes Care. 1992;15(11):1509-1516.
27. Jones KW, Cain AS, Mitchell JH, Millar RC, Rimmasch HL, French TK, et al. Hyperglycemia predicts mortality after CABG: postoperative hyperglycemia predicts dramatic increases in mortality after coronary artery bypass graft surgery. J Diabetes Complications. 2008;22(6):365-370.
28. Simsek Yavuz S, Bicer Y, Yapici N, Kalaca S, Aydin OO, Camur G, et al. Analysis of risk factors for sternal surgical site infection: emphasizing the appropriate ventilation of the operating theaters. Infect Control Hosp Epidemiol. 2006;27(9):958-963.
29. Salehi Omran A, Karimi A, Ahmadi SH, Davoodi S, Marzban M, Movahedi N, et al. Superficial and deep sternal wound infection after more than 9000 coronary artery bypass graft (CABG): incidence, risk factors and mortality. BMC Infect Dis. 2007;7:112.
30. Schmeltz LR, DeSantis AJ, Thiyagarajan V, Schmidt K, O'Shea-Mahler E, Johnson D, et al. Reduction of surgical mortality and morbidity in diabetic patients undergoing cardiac surgery with a combined intravenous and subcutaneous insulin glucose management strategy. Diabetes Care. 2007;30(4):823-828.
31. Trussell J, Gerkin R, Coates B, Brandenberger J, Tibi P, Keuth J, et al. Impact of a patient care pathway protocol on surgical site infection rates in cardiothoracic surgery patients. Am J Surg. 2008;196(6):883-889.